Anti-HSV-1 agents: an update
Herpes simplex virus type I (HSV-1) is a member of the α-herpesvirus subfamily and is capable of causing herpes simplex keratitis, herpes labialis, and herpes simplex encephalitis. HSV-1 is well known for its lytic infections at the primary sites and for establishing latency in the sensory neuronal...
Saved in:
Main Authors: | Wenwen Lv, Lei Zhou, Jia Wu, Jishuai Cheng, Yongzhong Duan, Wen Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1451083/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Untreated HSV Leading to Neonatal Death
by: Meghan Sawyer, et al.
Published: (2025-02-01) -
Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity
by: Solís-Cruz Guadalupe Y., et al.
Published: (2023-09-01) -
Investigation of the effıciency of pomegranate (punica granatum l.) peel extract on herpes simplex virus-1
by: Irmak Dik, et al.
Published: (2022-06-01) -
Advanced progress in the genetic modification of the oncolytic HSV-1 virus
by: Mi Zhou, et al.
Published: (2025-01-01) -
Next-generation sequencing and immuno-informatics for designing a multi-epitope vaccine against HSV-1-induced uveitis
by: He Cao, et al.
Published: (2025-01-01)